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licenses/by-nc-nd/4.0/).Despite the risks associated with twin and other higher-
order multiple births, and subsequent calls for single-embryo
transfer (SET) as the standard of care for good-prognosis
patients, most providers transfer additional embryos, raising
critical questions as to why this is the case. As a consequence6.07.001
er Ltd. This is an open access artof assisted reproduction via IVF, rates of twin and other
higher-order multiple births have increased over recent
years, essentially doubling between the mid-1970s and 2011
in many developed countries, including the UK, France,
Germany, the USA and South Korea (Osterman et al., 2015;icle under the CC BY-NC-ND license (http://creativecommons.org/
2 R KlitzmanPison et al., 2015). Critics have decried an ‘epidemic’ of
multiple births (Muir, 2001), and the case of ‘Octomom’ in
the USA – in which a woman on federal assistance gave birth
to octuplets following treatment with artificial reproduc-
tive technologies – brought world-wide attention to this
issue (Davidson, 2010).
When transferring more than one embryo, the rate of
complications increases. Among infants born to mothers
through IVF, twins are 12 times more likely than singletons
to be born prematurely, 16 times more likely to have low
birth weight, and about five times more likely to have
respiratory complications or jaundice (Sazonova et al.,
2013). Mothers of twins are about two and a half times
more likely than those of singletons to have pre-eclampsia,
over eght times more likely to have premature pre-term
rupture of membranes, and four times more likely to
require a Caesarean section (Sazonova et al., 2013).
Although some providers and patients may see twins as a
means of saving money, the overall cost per live birth (for
both mothers and infants) for one double-embryo transfer
(DET), rather than two SET, until 6 months of age, are
roughly equal, given neo-natal intensive-care unit (NICU)
and other expenses (Thurin-Kjellberg et al., 2006). Over
time, twins can cost even more, given the associated
long-term complications (Collins, 2007; Wølner-Hanssen
and Rydhstroem, 1998).
Opponents of establishing SET as the standard of care for
good-prognosis patients argue that twins are desirable, and
that the reported risks are exaggerated (Gleicher and Barad,
2009). A meta-analysis of studies published from 1995–2008
(Baruffi et al., 2009) found that DET had about twice the
pregnancy and birth rate of SET. Yet over the past decade,
since many of these studies were conducted, SET success has
increased substantially, while higher complications with DET
continue. A more recent meta-analysis (McLernon et al.,
2010) found that the birth rate from a fresh SET followed by
a frozen SET was not significantly different than that of one
fresh DET (38% versus 42%), and that the risks of a preterm
birth were five times higher for DET than for SET. One Italian
centre recently suggested that twin pregnancies compared
with singleton pregnancies had 31.8 times the rate of
perinatal complications (La Sala et al., 2016). Other data
show that for women over 40, transferring three, rather than
two embryos does not increase the live birth rate (Lawlor
and Nelson, 2012).
Therefore, as SET success rates continue to rise, com-
mentators have increasingly argued that SET should become
the standard of care (Kissin et al., 2015), and that this may
be achievable through altering insurance reimbursement,
providing appropriate educational materials and including
patients’ partners in discussions of risk (Griffin et al., 2012;
Hope and Rombauts, 2010; Leese and Denton, 2010).
In recent years, guidelines in various countries have
thus sought to reduce the number of embryos transferred,
including the UK (HFEA, 2013), Australia/New Zealand
(Norman, 2016), and Canada (Canadian Fertility and
Andrology Society, 2006). The number of countries that
limit the number of embryos to be transferred has been
steadily increasing, and in 2013 was around 17 (Stillman et
al., 2013). In the UK, the Human Fertilization and Embryol-
ogy Authority (HFEA) has progressively lowered the maxi-
mum multiple birth rate from 24% in 2009/2010, to 15% in2010 and 10% in 2012 (HFEA, 2013). Belgium coupled
reimbursement for assisted reproductive technologies to a
restriction in the number of embryos transferred and
reduced the multiple pregnancy rate from 27% in 2003 to
11% in 2010 (De Neubourg et al., 2014). However, many
countries still allow considerable room for physician discre-
tion. The American Society of Reproductive Medicine
(ASRM), for instance, states that ‘physicians should be
encouraged to counsel good-prognosis patients to accept’
SET; and highlights the importance of clinical judgement
in selecting the best candidates (The Practice Committee
of the ASRM, 2012). For patients b35 years of age with a
favourable prognosis, ‘providers should only transfer a single
embryo, and not more than two embryos’ (The Practice
Committee of the ASRM and the Practice Committee of
the SART, 2013). For patients aged 38-40, and 41-42, ASRM
states that no more than three and five cleavage-stage
embryos, respectively, should be transferred. Patients,
who have failed two or more IVF cycles or have a less
favourable prognosis, can receive an additional embryo.
For patients aged over 43, there is no limit (The Practice
Committee of the ASRM and the Practice Committee of the
SART, 2013).
Since 1998, the rate of twin and multiple births have
begun to decrease – as providers have begun to transfer
three or more embryos less frequently (Kulkarni et al.,
2013) – but remain higher in numerous countries than many
observers argue is optimal. Thus, 17% of all Canadian births
were twins in 2013 (Canadian Fertility and Andrology
Society, 2006), and multiples accounted for approximately
17% of British pregnancies (HFEA, 2013) and 19.4% of all
births in Europe in 2011 (Kupka et al., 2016). Among cycles
using IVF and intra-cytoplasmic sperm injection (ICSI),
transfers of three and four embryos accounted, respectively,
for 14.5% and 1.3% in Europe as a whole, including 49.4% and
9.9% in Greece, 34.6% and 4.5% in Italy, 26.2% and 3.1% in
Hungary, and 40.7% and 7.9% in Bulgaria (Kupka et al.,
2016). Twin and triplet deliveries accounted for 18.6%
and 0.6% of assisted reproductive technology births using
IVF and ICSI in Europe as a whole, including, 41.5% and 3.5%
in Greece, 28.2% and 1.7% in Romania, 22.0% and 6.5% in
Moldova, and 26.5% and 5% in Serbia (Kupka et al., 2016).
The most recent summary data available from the Society
for Assisted Reproductive Technologies (SART) from 2013,
suggests that among all transfers using fresh non-donor eggs
or embryos, 76.4% involved one or more embryos and 20.7%
involved three or more embryos; and the average number of
fresh and thawed embryos from non-donor eggs transferred
in women under 35 was 1.8% and 1.7%, respectively (Centers
for Disease Control and Prevention, 2013). Among live births
from fresh embryos, for mothers under 35 and aged 35-37,
respectively, 28.3% and 25.5% of US births were twins and
approximately 1% were triplets or higher-order multiples.
The SART Clinic Summary Report (2016) lists the percentage
of cycles, retrievals and transfers resulting in live births, but
does not separate these data by the number of embryos
transferred (1 versus 2 or more). The success rates would
presumably be lower for singletons (versus twins).
A few studies have suggested that physicians may fail
to follow SET because of patient requests. A literature
review revealed that most patients prefer twins rather than
singletons (Leese and Denton, 2010). In one study, 52% of
3How many embryos to transferclinicians were found to deviate from ASRM’s guidelines
concerning embryo transfers due to patients’ requests,
51% deviated when using frozen embryos, and 70% did so
when patients had failed prior IVF, and only 34% routinely
discussed with all patients SET (Jungheim et al., 2010). In
certain developing, as well as in developed countries, most
patients prefer transfer of at least two embryos, and
providers often comply with these requests
(Balasubramanyam, 2010).
Though some commentators have argued that patients’
preference for twins results from limitations in insurance
coverage of assisted reproductive technology, the data
concerning this claim are mixed. In the USA, states that
mandate some IVF insurance coverage have slightly lower
rates of twins (26% versus 28%) and triplets (3.4% versus
3.9%), though the absolute differences are not high (2% and
0.5%, respectively) (Martin et al., 2011). Twins and other
multiple births are also far more common in the USA than
in several other countries, possibly due to differences in
insurance coverage (Chambers et al., 2014). However, in
a study in Denmark, where two embryo transfers and three
IVF cycles were reimbursed, 59% of patients nonetheless
preferred twins because of desires for siblings and reduction
of physical and psychological stresses from undergoing IVF –
not because of economics (Højgaard et al., 2007). Yet in this
study, though all subjects had received counselling with
a nurse concerning the risks of twin pregnancies, 58.4%
of participants stated that they had not received oral
counselling on the advantages and disadvantages of twin
pregnancies; and of those who said they had received such
counselling, 32.3% said they needed additional information.
Among the 58.4% who said they had not received counsel-
ling, 70.6% said they needed additional information on twin
pregnancies. Hence, most of these subjects who preferred
twins may not have understood or appreciated the
risks involved. Murray et al. (2004) also found that most
patients preferred DET, even if receiving an extra leaflet
or 10-minute conversation with a nurse about the issues
involved. Critical questions thus arise of exactly how
patients and providers communicate and interact regard-
ing these issues – how providers discuss these issues with
patients, why most patients fail to recall these conversations,
and how patients view and understand these potential
risks.
Same-sex male couples may also often prefer twins so
that each will have a biological child (Greenfeld and Seli,
2011). Moreover, Jungheim et al. (2010) found that clinics
where fewer than half of all IVF cycles were self-financed
were much less likely to limit the number of embryos
transferred due to patient requests than did clinics where
more than half of all IVF cycles were self-financed.
Additionally, the amount of insurance held had no effect
on deviations due to previous failed IVF cycles, or use of
frozen embryos. Jungheim et al. (2010) suggested that
patients with insurance may want to take aggressive
approaches after IVF failure; but presumably patients
without insurance would want to do so as well. These
researchers suggested, too, that clinics with a higher
number of insured patients had less SET because of more
competition from other IVF clinics. Yet research has shown
that as competition increases between assisted reproductive
technology clinics in a city, higher-order multiplepregnancies (triplets or more) using non-donor eggs de-
creases slightly (from 8.43% to 8.24%) (Steiner et al., 2005).
Whether competition decreases rates of twins is unknown.
Other factors may thus be involved in patients’ opposition
to SET. Patients, surveyed in 1999–2000, overestimated
rates of premature, low birth weight and death of low-birth
neo-nates, yet 68% still felt that a twin pregnancy was
desirable. Only 58%, however, remembered being counselled
about the risks of multiple births, and the median length of
the counselling, they recalled, was only 5 min (Kalra et al.,
2003). In a study of college students, persuasive communi-
cation strategies and highlighting the risks involved led
respondents to prefer SET (van den Akker and Purewal,
2011).
Though some observers have argued that to decrease the
rate of twins, insurance coverage for IVF should be increased
(Johnston et al., 2015), this proposed policy change may
be more likely in countries with a nationalized, single-
payer health system (e.g., Belgium), as opposed to a more
privatized system, such as in the USA, where several
obstacles arise. Infertility, since it does not increase mor-
tality, may be seen as being less of a public health priority
than lethal disorders (e.g., cancer and heart disease). In
many countries, increasing insurance to cover unlimited
fertility treatment for all those who seek it (heterosexual
couples, single men and women and same-sex couples)
would be extremely costly. Hence, it remains unclear
whether sufficient political will exists in many countries to
mandate that insurance companies cover IVF for everyone,
whether this change will occur, and if so, where, when and
by how much. Opponents may argue, too, that multiple
births can be avoided easily by physicians simply transferring
fewer embryos.
Research is urgently needed to examine factors that shape
patients’ and physicians’ attitudes about the number of
embryos transferred, particularly concerning acceptance of
using more than one IVF cycle (ASRM, 2012); yet such research
remains scant. No further studies of assisted reproductive
technology providers’ practices or attitudes concerning these
issues have been published since Jungheim’s 2010 survey,
which raised many unexamined questions, for example, why
most physicians deviate from guidelines in various situations.
Extensive literature searches have found no other studies
of how providers view these issues – why they have not
fully followed recommendations to transfer fewer embryos,
and what challenges, if any, they face.
Crucial questions thus remain of why professional orga-
nizations in many countries and many IVF providers con-
tinue to allow twin births, despite the risks. How do
providers and patients perceive, understand and negotiate
these tensions and make these decisions? What do
providers do and why? How do they decide what to do
when patients prefer twins, do conflicts persist, and if so,
how do providers address these? Given that obstacles will
be likely to impede significant increases of insurance
coverage for assisted reproductive technology in many
countries, it is vital to explore these questions, to grasp
what other approaches, if any, might help reduce the
number of twin births.
Thus, as part of a study of how providers and patients
view and make decisions concerning several key aspects of
IVF use, these issues were examined.
4 R KlitzmanMaterials and methods
In brief, as summarized in Table 1, and described elsewhere
(Klitzman, 2016) 37 in-depth semi-structured interviews of
approximately 1 h each were conducted in the USA with 27
assisted reproductive technology providers –17 physicians and
10 other providers (seven mental health providers, two nurses
and one other) – and 10 patients. One physician and three
other providers were also themselves patients. Patients and
providers were recruited through electronic mailing lists
(listservs), direct emails and word of mouth. Providers were
also recruited through national ASRM meetings (e.g., preim-
plantation genetic disorders [PGD] and mental health provider
interest group meetings). Attendees were approached to
ascertain if they might be interested in participating in an
interview study, and if so, information was subsequently
emailed to them about it. Most of those asked agreed to
participate and did so. A mental-health listserv was used,
which is received by approximately 60 members (not all of
whom are active), of whom 15 responded, and eight were then
interviewed. Additional interviews were conducted as back-
ground, for informational purposes, with eight physicians,
nine mental health providers and 14 patients, and informed
(but were not included in) the final formal data analysis.
Interviews for the formal data analyses were conducted with
each group until ‘saturation’ was reached (i.e. ‘the point at
which no new information or themes are observed in the data’;
Guest et al., 2006). Interviewees were from across the USA.
Interviews explored participants’ views and decisions
regarding ethical issues concerning several aspects of
assisted reproductive technology, and were systematically
analysed to obtain detailed descriptions of these issues.
Providers described various patients they had treated, and
interactions with colleagues; and patients often described
interactions with various providers and other patients.
From a theoretical standpoint, Geertz (1973) has advocated
studying aspects of individuals’ lives, decisions and social
situations not by imposing theoretical structures, but by
trying to understand the individuals’ own experiences,
drawing on their own words and perspectives to obtain a
‘thick description’. The methodology adapted elements from
Grounded Theory (Strauss and Corbin, 1990) and was thus
informed by techniques of ‘constant comparison’ with data
from different contexts compared for similarities andTable 1 Characteristics of interviewees.
Male Female Total
Physicians 14 3 17
Physicians who are also patients 0 1 1
Type of practice
University affiliated 5 1 6
Private practice 9 2 11
OTHER assisted reproductive
technology providers
(e.g., mental health providers,
nurses)
1 9 10
Other providers who are also patients 0 3 3
Patients 1 9 10
TOTAL 16 21 37differences, to see if they suggest hypotheses. This technique
generates new analytic categories and questions, and checks
them for reasonableness. These methods have been used
in several other studies examining key aspects of health
behaviour and doctor-patient relationships and communica-
tions in genetics and other areas (Klitzman, 2012, 2013;
Klitzman and Daya, 2005; Klitzman et al., 2007, 2013).
The questionnaire (see Appendix for sample questions)
was drafted, drawing on prior literature. Transcriptions and
initial analyses of interviews occurred during the period
in which the interviews were being conducted, enhancing
validity, and helped shape subsequent interviews. Interviews
were conducted via phone. The Columbia University Depart-
ment of Psychiatry Institutional Review Board approved the
study, and all participants gave informed consent.
Once the full set of interviews was completed, subse-
quent analyses were conducted in two phases, primarily by a
trained research assistant and the Principal Investigator. In
phase I, they independently examined a subset of interviews
to assess factors that shaped participants’ experiences,
identifying categories of recurrent themes and issues that
were subsequently given codes. The Principal Investigator
and research assistant read each interview, systematically
coding blocks of text to assign ‘core’ codes or categories
(e.g., issues concerning whether and why to transfer more
than one embryo, and who decides). While reading the
interviews, a topic name (or code) was inserted beside each
excerpt of the interview to indicate the themes being
discussed. The Principal Investigator and research assistant
then worked together to integrate these independently
developed coding schemes into a single scheme. Next, they
prepared a coding manual, defining each code and examin-
ing areas of disagreement until reaching consensus. New
themes that did not fit into the original coding framework
were discussed, and modifications made in the manual when
deemed appropriate.
The research assistant and the Principal Investigator then
independently content-analysed the data to identify the
principal subcategories and ranges of variation within each
of the core codes. The sub-themes identified by each coder
were reconciled into a single set of ‘secondary’ codes and an
elaborated set of core codes. These codes assess subcate-
gories and other situational and social factors, including
subcategories such as the desire to transfer more than one
embryo because of lower costs, or a belief that the data on
twins having more complications than singletons were not
compelling; and decisions being made by patients versus
providers versus a committee.
Codes and sub-codes were then used in analysis of all of the
interviews. To ensure coding reliability, two coders analysed
all interviews. Where necessary, multiple codes were used.
Similarities and differences between participants were
assessed, examining categories that emerged, ranges of
variationwithin categories and variables thatmay be involved.
Areas of disagreement were examined through closer
analysis until a consensus was reached through discussion.
Consistency and accuracy in ratings were checked regularly
by comparing earlier and later coded excerpts.
To ensure that the coding schemes established for the
core codes and secondary codes were both valid (i.e. well
grounded in the data and supportable) and reliable (i.e.
consistent in meaning), they were systematically developed
5How many embryos to transferand well-documented. Data were also examined in the
context of issues in the literature, posing questions and
collecting sufficient details to substantiate points that
arose.
Given the ASRM's recommendations that providers devel-
op policies, the scant data that exist on how providers view
these issues, and the absence of prior research on key
aspects of clinicians' views and practices concerning these
issues (e.g., the processes by which they decide how many
embryos to transfer), this paper focuses on provider
attitudes and practices, rather than those of patients.
Results
Overall, as seen in Fig. 1, providers and patients alike
wrestle with issues surrounding the number of embryos to
transfer. Although clinics tend to follow ASRM guidelines,
these allow a degree of flexibility, and contain ambiguities.
Decisions about how many embryos to transfer emerge as
dyadic and dynamic, and affected by several factors,
fostering differences in whether, how, and with what effec-
tiveness clinicians address these issues with patients.
Given the increasing success rate of IVF and concomitant
increase in multiple births, several – but by no means all –Why implant only 1 embryo?
• Multiple births have more complications for:
o Infants
o Mothers
• Success rates per transfer are improving over time
• But rates of multiple births remain relatively high
Patients’ reasons:
• Medical:
o Odds of success:
Can be uncertain and low 
Desires to decrease:
• Discomfort
• Inconvenience
• Psychological:
o Emotional:
Patients often: want more 
embryos implanted
• Feel desperate for a child 
Don’t always have much 
time to weigh these issues
Want to avoid retrospective 
regrets
o Cognitive:
Patients may:
• Minimize risks
• Misunderstand 
risks/statistics
Providers may not always 
explain risks well
The media can foster 
misunderstandings of risks
• Financial:
o To reduce costs
o Often not covered by insurance
Physicians’ reasons:
• Medical:
o Having to balance competing 
sense of odds
o Uncertainties are involved
• Professional/Institutional:
o Data seen as not compelling
o Desires to avoid 
retrospective regrets
o Physicians’ financial 
considerations
o Competition between clinics
in other countries
• Regulatory:
o Limitation of current 
reporting system
Reporting number of 
embryos is not mandatory
in many countries
Why implant >1 embryo?
Fig. 1 Issues concerning the nuproviders have decreased to a certain degree the number of
embryos they transfer. Although several clinicians felt that
the need to transfer only one embryo, rather than two, was
clear (‘Even twins are dicey.’ [Other provider-patient #10]),
in general providers appeared to end up transferring addi-
tional embryos, due to both the patients’ and the providers’
views and goals.Patients’ perspectives as they affect providers’
practice
Medical factors: low and uncertain odds of success
Given that the odds of success are uncertain and less than
50%, many prospective parents, especially those who have
failed to get pregnant previously, are eager simply to have a
baby, and thus ignore or discount the risks involved. One
41-year old patient said:
I never feared multiple pregnancies, because we just wanted a
baby. We should have been thinking – but weren’t – ‘what are
we gonna do with two or three?’ We thought, ‘Whatever it will
be, will be.’ [Patient #9]How to decide?
• What factors to weigh?
o Patients and providers 
often struggle to balance 
these factors
o Benefit to patient vs.
risks to patient, future 
child, and to society
o Prioritizing patient 
autonomy
• Just saying ‘No’
• Implanting >1 embryo 
and reduce fetuses
later, if needed
• Who decides?
o Ethics or Quality 
Assurance committee?
Implications
• Changing policies?
o Change reporting 
requirements
Require SART 
reporting numbers of 
embryos transferred
o Increase insurance 
coverage of IVF 
• Increase education of 
providers and patients
• Improve practice
o Enhance communication, 
and awareness regarding 
these tensions
• Needs for additional research
o In many countries
mber of embryos to implant
6 R KlitzmanPatients often struggle with these questions, aware
of the conflicting pros and cons and feel unsure how to
proceed. Patients may therefore opt to transfer an addi-
tional embryo when a single one might suffice. As one
patient said:
I struggled with: Do we put two in because one might not make
it? What if both take? What if we put in one and it doesn’t work,
and we then have to do it all over again? And how do you choose
which one to put in? If we do another cycle and have two, I would
transfer only one, because I know now for sure that I carry very
well. My problem is getting healthy eggs, not necessarily carrying
them. If your problem is carrying them, I would be more inclined
to put in two. But if this was my first cycle, and we had two,
I don’t know what we would have done. [Patient #4]
The vagaries involved can make decisions about how
many embryos to transfer very difficult for patients.
Questions also arise concerning when providers do
and should discuss these issues with patients. Given the
uncertainties involved, clinics may not know in advance the
number of viable embryos available, and thus offer patients
scant time to make these decisions:
Our clinic doesn’t actually tell you how many eggs or embryos
you have until you are ready to do the transfer. The doctors said
they’d call us that morning. But they don’t tell us the actual
number until we’re on the gurney and ready to go. So you don’t
have time to really think how many you want to put in or freeze.
If you have three, is it worth freezing just one, or freezing two in
and putting one in? [Patient #4]
Psychological factors
Patients may dismiss, minimize or deny the risks and possible
harm to themselves and children born as multiple births, and
may seek to rationalize their decisions:
Most patients are pretty much in denial: ‘It won’t happen to me’.
By now everybody should know somebody who’s had twins who
ended up in a NICU. But they don’t care. They think it won’t
happen to them. [Other provider-patient #9]
Partly, patients may have competing needs, desires,
anxieties and stresses. ‘Patients are very fickle because
they’re desperate, looking for magic guarantees.’ [Other
provider #5]. Consequently, patients may not fully grasp the
dangers involved, and focus only on the potential benefit –
having a child (‘Most women don’t understand the risks. A
lot of women want to get it over with.’ [Other provider-
patient #9]). In fact, the statistics are not straightforward,
and patients may therefore miscomprehend or be misled
by them:
Most people don’t understand the statistics. Some patients look
at pregnancy statistics as opposed to take-home baby statistics.
Statistics can also be moved around. Statistics on live births are
inflated by the number of multiple pregnancies. Patients don’t
really understand the numbers, unless they’re a researcher.
[Other provider #5]Misunderstandings partly reflect insufficient education
about these complications among patients and the public at
large:
40% of women say they would rather have quadruplets than
have nothing. Because the public has no idea how devastating
prematurity is. In part, the popular press is not reporting the
problem of multiple births well. [Physician #10]
Media reports can also promote inaccurate understandings
of the odds and dangers involved. Cases such as ‘Octomom’
can lack important detail and follow-up:
The media isn’t quite getting multiple pregnancies. Even with
the octuplets, six are doing fine, breathing and having blood
pressure. The press doesn’t talk about what they’re going to look
like later. [Physician #10]
Providers may also not necessarily communicate with
patients adequately about these risks, because of compet-
ing goals. Doctors themselves may want to increase their
success rates, and thus not fully inform patients of the
potential dangers. As one mental health professional said:
The amount of information given to patients is woefully inade-
quate. Clinics want to keep up their numbers. Most patients are
not informed of the risks of having twins. The only therapy patient
I’ve had who was fully informed of those risks was herself a doctor,
and she agonized for a long time about what would happen if both
of the transferred embryos took. The field is moving toward SET.
But I’m not sure if patients are adequately counselled about the
success rate of those treatments. [Other provider-patient #9]
Burdens on patients
Patients may also want twins, rather than two separate
pregnancies, to reduce financial as well as physical and
psychological stresses and burdens involved with each cycle.
Providers are often acutely aware of the financial pressures
on patients. ‘Patients should have insurance that would
help us provide care to everybody. Then, we would have
greater ability to do single-embryo transfers.’ [Physician #7].
Patients confront both financial and non-financial burdens:
A 35-year-old friend had IVF, and had twins and had to pay
100% out of pocket. If I were in her place, I would be more likely
to transfer two. I wouldn’t want to have to go through this all
over again, and lay out more money. [Patient #4]
Individual patients face not only improved odds of a
take-home baby, but lower expenses, which physicians in
other areas of medicine, generally covered by insurance,
may not normally consider. ‘It’s hard to argue against people
wanting to transfer two because of cost.’ [Physician #1]
Physician perspectives
Medical factors
In trying to estimate the odds of success per embryo for any
one patient, providers balance several competing sets of
7How many embryos to transferstatistics, including their own overall experience and effec-
tiveness with past patients:
When we transfer two, usually only one takes. So we transfer
two. We have less than 20% twins. If our rate of twins was higher,
we probably would go to SET. Transferring three? Extremely
rare. We might consider it on frozen embryos: if the couple
has gotten to the end of the frozen ones, and three are left,
we’ll probably transfer three. If we had a lot of recipients get
pregnant with twins, the doctors would feel more comfortable
doing single-embryo transfers. [Other provider #7]
Still, questions arise as to what rate of twins would be
high enough to prompt SET.Professional and institutional factors
The data ‘aren’t compelling’
Importantly, not all providers feel the data are suffi-
ciently compelling regarding the risks involved in multiple
births. One physician said about the risks involved when
a patient, pregnant with triplets, refuses to reduce the
number of fetuses, ‘Triplets are a little grey. Quadruplets
not grey at all. Twins are really not grey.’ [Physician #7].
Concerning a patient who ultimately refused to reduce
from three fetuses, this physician added:
If the data were compelling – if she had quadruplets – I’d
say, ‘You really do need to get this done.’ But I think that for
triplets, the data are not compelling enough for me to say that.
[Physician #7]
Providers may thus weigh their views of the data,
especially in the face of strong patient desires to have
more than one child. Yet many commentators have strong-
ly disagreed that the evidence is insufficient, given the
relatively high rate of complications faced by twins and
triplets. Questions thus arise of exactly how compel-
ling the evidence would need to be to alter more
providers’ practices.
Providers who have seen close-up the physical harm of
multiple births may perhaps be more convinced. Providers’
concerns may in part reflect their own experiences:
I have seen first-hand what could happen: I know people who
went through IVF, and ended up with extremely premature infants
in the NICU, born at 25 weeks. Another set of twins are now 15, but
one’s extremely disabled. [Other provider-patient #9]
Yet physicians who feel that the data are insufficient may
consequently mention or discuss these risks with patients,
little, if at all:
Some physicians in our programme just tell the patient, ‘You
have two blastocoels’, put back two, and don’t even talk to them
about one. Maybe twins isn’t bad; we’re over-exaggerating it.
But it’s still an admirable goal to try to cut down the amount of
twins. [Physician #10]
The marginal increased risks may be low for each
individual patient, but become of concern from a broader
public health perspective; yet providers may only factorthese larger social costs when they have themselves witnessed
or experienced them.
Doctors and patients may also transfer more embryos
than needed to avoid later retrospective regret, frustration
and anger. ‘If we put two in a 37-year-old and she doesn’t
get pregnant, then you say, ‘Maybe I should have put in
three instead.’ [Physician #11].
Benefits to physicians
Providers may support patients’ desires for twins partly
because doing so can help doctors with their own success
rates or profit, given competition for patients. Physicians
may agree to additional embryo transfers in order to
increase their published success statistics:
Part of the motivation for some physicians is to get their numbers
up of take-home babies per cycle. Other doctors want patients
to get pregnant, and know that a slightly better way is to put in
two embryos, in spite of all the recent evidence that if you’re
under 35, one embryo would pretty much work as well as two.
[Other provider-patient #9]
Providers may also seek to satisfy and thereby keep
their patients, which can further prompt transfer of two
or more embryos. ‘People are moving toward SET, but
not so quickly – it is very competitive. Big money.’
[Other provider #5]. One physician transfers just single
embryos, but feels able to do so only because of a lack
of competition – no other clinic exists within hundreds
of miles:
More clinics don’t transfer only one – because of competition.
The other nearest IVF centre is three or four hours away from us.
In contrast, if you have a clinic down the hall, and you say, ‘No
I’m not going to do that,’ patients say, ‘Fine,’ and go there. It’s
monetarily and competition driven. [Physician #1]
The number of clinics in a particular geographic area may
thus affect clinic policies.
Regulatory
Effects of current reporting requirements
Providers may also be very motivated by the need to
report success rates per cycle (‘It’s hard to find a
private practitioner who is not intently aware of the
statistics.’ [Physician # 11]). Many physicians want to
improve their statistics; and the current data-reporting
rules require that providers list pregnancy rates (but not
implantation rates), further motivating transfer of extra
embryos:
The reporting system disincentivizes transferring fewer embry-
os. We look mostly at pregnancy rates, rather than implantation
rates. So in many programmes, if a patient doesn’t want to put
only one embryo back, nobody will argue with them. If the
guidelines say one, a lot of patients want to put back two.
Doctors say, ‘Fine.’ But if we were looking at implantation rates
rather than pregnancy rates, your implantation rates can be
better if you put back one, and you might be a little bit more
persuasive with your patients who are trying to decide between
one and two. [Physician #10]
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of embryos transferred, but significant obstacles can impede
such changes:
I’ve been pushing for change for years. Implantation rates are
very down in the depths of the reporting system. I’m kind of
radical: you shouldn’t report pregnancy rates at all because
people are going to look at pregnancy rates because they
understand it. If you reported implantation rates without
pregnancy rates, they’d have to look at that. You can explain
what it is, and they’d be able to judge a programme better,
because implantation rate is a better judge. But I don’t think
that’s going to come to be. [Physician #10]
Reporting is in fact optional rather than mandatory
for physicians in many other countries, where the doctors
do not all list their success rates, perpetuating problems.
Concerning the so-called ‘Octodoc’, for instance, one
physician said:
On his success rates page, there are no success rates…He
doesn’t report SART. He doesn’t have to. You can choose not to.
Transferring double embryos skews success rate data, but does not
necessarily mean that those clinics are more successful. That’s
double-speak right there. It just means that their patients have
a 13%-33% chance of twins versus our 8% of twins. [Physician #9]
In various ways, doctors may also manipulate the data
they provide. Physicians felt that to get good rates, some
colleagues carefully selected or rejected certain patients, or
only treated patients with very high-quality embryos:
A little bit ‘icky’ are doctors who do minimal IVF stimulations.
It’s supposed to be minimal stimulation, but I saw a patient who
was on about 300 gonadotrophins. He won’t do a transfer unless
you make a nice blast[ocyst]. So she underwent five stimulations
– five egg retrievals for a cumulative of 10 eggs retrieved and she
had only one embryo transferred. He’s playing with his rates,
only transferring high-quality blasts. Other patients don’t get a
transfer, so he can report that he has a good pregnancy rate per
transfer. He tells people what they want to hear. He doesn’t talk
about the fact that she still had five surgeries and five retrievals!
Minimal stimulation is great, but really the risk of IVF is the egg
retrieval, not the stimulation. That has a very high ‘ick factor’
for me because it’s a snake-charmer practice: ‘You don’t want
to take drugs? You don’t have to take drugs. We can do just as
good: Look at our rates!’ But, the right answer is somewhere
in between the European model of stimulating less and our
model of stimulating more. Pregnancy rates in the US are easily
30%, if not 50% better than Europe. Yes, we have more multiples,
but that’s because we have a much higher implantation rate.
[Physician #9]
Providers may also ‘game’ the statistics and produce
twins to improve their reported rates, though still following
the guidelines, broadly speaking:
People are choosing patients based on the FSH or their ovarian
reserve, cherry-picking the best patients to try to have their best
results. So they’re transferring more embryos than they should.
[Physician #11]Yet gaming the statistics can produce problems – most
egregiously with Octomom:
Octomom was a terrible outcome. To try to improve pregnancy
rates, the doctors were putting back more and more embryos,
and in one case got burned. [Physician #1]
Clinics may manipulate reported rates in other ways
as well – e.g., by having separate, non-reported, ‘research’
protocols:
We all believe that one particular institution has two protocols,
a research protocol, where they put through their high FSH
patients, and don’t do anyone else with a FSH greater than 10.
[Physician #9]
But often, providers are still not entirely sure of these
colleagues’ practices.
To boost their reported success rates, providers may also
select or refuse to treat patients in various ways, and reject
certain patients whom other physicians might accept:
Doctors differ somewhat in turning away patients who have a
reduced prognosis for pregnancy. We get patients who have been
turned away elsewhere for things like elevated FSH. The other
provider doesn’t want to treat them. I feel, depending on their
prognosis, that for patients with a 10% likelihood of pregnancy,
as long as they’re adequately counselled, treatment may not be
unreasonable. [Physician #7]
Questions therefore arise, too, of whether to treat
patients with low odds of success, and if so when, in what
way and how to decide.
The quality of reported data can also vary widely – the
completeness, accuracy and validity of diagnoses or out-
comes. Consequently, data from Europe may not always be
fully comparable:
The more data you get, the less accurate it is. Those of us who
are academic and/or involved with SART are very gung-ho about
getting the data, and putting it in appropriately. But a lot
of programmes see it as another task to do, and just put in
whatever data are the fastest to put in. The more you do
that, the more problems you’re going to have. You end up
with numbers, but they may not be accurate, particularly with
diagnosis. How do you diagnose male factor in an IVF cycle?
Doctors handle ovulatory factor and endometriosis differently.
Or ovarian reserve – half the time people forget that that even
exists in the diagnostic codes. So when you start getting too
much data, people are not interested in putting the information
in; or the numbers are subjective. You get the numbers, but
what do they mean? [Physician #10]
Processes of decision-making: how to decide
Prioritizing patient autonomy versus other factors
Clinicians may face conflicts with patients’ desires and
then have to decide how to proceed. Patients may push to
have additional embryos transferred, prompting difficul-
ties or contentious discussions – whether, depending on
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autonomy:
In the ‘how-many-embryos-to-transfer?’ conversation with a
42-year-old who wants six because she gets the math, you say,
‘I don’t want to do six,’ or, ‘No, I won’t do that.’ They say,
‘They’re my embryos!’ I say, ‘Well, I have to follow our pro-
fessional society guidelines and I won’t deviate from: no more
than five.’ [Physician #9]
When patients request additional transfers to increase
their odds of success and decrease their out-of-pocket costs,
providers may have difficulty weighing the clashing consid-
erations involved. Clinicians vary in whether to yield to
these requests, and if so, when:
With our single-embryo transfer policy, we wrestle with the
competing ethical areas of patient autonomy versus the physi-
cian’s social responsibility to do what’s right for society. The
patient says, ‘I want two embryos because I want twins.’ You
say, ‘Well, twins are not a good outcome. They have premature
delivery and use up resources more rapidly. It’s very expensive,
and we can’t avoid it.’ ‘Well, I want them anyway.’ [Physician #1]
Providers vary in how they then proceed – whether
effectively to let the patient decide, reflecting in part rising
patient consumerism:
Who makes those decisions? Doctors used to make all the calls:
this is the way we do it. Patients were accepting. Lately, it
seems that the patient gets whatever she wants. Doctors throw
up their hands and say, ‘Well, that’s what she wanted.’ That’s
ridiculous! It shouldn’t remove the responsibility from the
physician. At what point should a physician say, where excessive
healthcare costs are involved, ‘No, we’re not doing that’?
Healthcare costs are increasing hugely because of the attitude:
we can do it. We get paid to do it. But no one asks should we do
it. [Physician #1]
Providers frequently see these dilemmas as fundamen-
tally ethical, recognizing underlying tensions of how to
balance individual patients’ desires against broader health
costs to society as a whole. These attitudes may also be
changing over time.
Who decides: the physician versus ethics or QA
committees?
Physicians face questions of whether they should make
these decisions on their own or in conjunction with other
professionals. Providers differ, too, in whether they consult
with a Quality Assurance (QA) or other type of committee. A
physician in a private practice said:
If anything looks exceptional, we bring it to QA for all of us to
discuss. Our patients sign a consent form about how many
embryos to transfer. It hurts our pregnancy rates, but we don’t
treat our pregnancy rate. We treat our patients. We are very
proud of American pregnancy rates, but we need to get our twin
and triplet rates down. If you freeze them and do one, and then
another one in another cycle, you’re almost as good as if you
were to transfer two at one time. [Physician #13]The type of clinic can shape these decision-making
processes. Providers who work within academic medical
contexts or hospitals can face additional implicit and explicit
pressures:
My hospital had a meeting of the medical executive directors
with 500 people, and they had me talk with a maternal-fetal
specialist about the impact of IVF on the hospital. I thought it
was going to be a lynching. I’m independent, but on staff at the
hospital. I’m not there very often; I do outpatient things and am
not tied by the hospital or run by them. You’d be amazed at the
cost for twins or occasionally triplets. From a cost point of view,
you want to have singletons because the complications other-
wise are difficult. I have patients who lose twins at 23 weeks.
Some complicated twin pregnancies are in bed for six months.
It’s a risk and a cost issue. I have competitors in my region with
pretty terrible records: triplets, quads. [Physician #11]
Hospital environments, in which physicians periodically
have to present their work to others outside assisted re-
productive technology, can thus act as a form of oversight or
social control.Implications: changing guidelines or policies?
The fact that relatively high rates of both twin and
higher-order multiple births continue poses critical ques-
tions concerning the need for possible additional guidelines,
or for regulations. Competing potential risks and benefits
of such additional policies need to be weighed against
each other. These clinicians opposed rules (rather than
guidelines), or stricter mandates that would diminish their
autonomy – stressing that clinical judgment can play an
important role in these decisions. ‘Unfortunately, some
doctors don’t exercise appropriate judgment, or follow the
guidelines, and act like cowboys and cowgirls, and make the
rest of us look bad.’ [Physician #7]. This physician acknowl-
edges potential limitations of the approach of simply
following patients’ autonomy – physicians may not all use
their ethical judgment to follow an alternative course. Yet
even though providers may not all follow certain guidelines,
they tended to oppose more stringent approaches, feeling
that current guidelines, rather than tighter regulations,
suffice:
The question becomes: What exactly is a guideline? Should
doctors be punished for not adhering? Should there be rules,
rather than guidelines? No! We’re taking care of individual
patients. [Physician #7]
Yet, while preferring suggested guidelines – rather than
regulations – this doctor nonetheless queries their scope,
meaning and implications. A broad continuum exists of levels
and types of guidelines, based on several characteristics
(e.g., whether violators will be disciplined) and their imple-
mentation and enforcement.
Providers may feel that changes to the reporting policies
are needed, but will be elusive due to the complex federal
bureaucratic structures and processes involved.While changes
in reporting requirements may have helped decrease the rates
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frequency of twins may be harder:
The CDC [Centers for Disease Control], to change, goes
through a huge bureaucracy – the OMB [Office of Management
and Budget]. So SART says: ‘We don’t want to do it because
people will go to the CDC more – because they’ll understand
the pregnancy rates better than they’ll understand implanta-
tion rates.’ SART is probably going to make changes and push
to the top line percentage of retrievals that end up with a
single baby, because that’s in there too, but buried. I think
there’s some movement to at least push that into the top,
which would be almost as good as implantation rates. Because
that has to be the incentive. The CDC basically says, ‘We want
you to report pregnancy rates and decrease the multiple
pregnancy rates,’ but these two goals conflict with each
other. It’s very hard to change it. They are very interested,
but there is that conflict. They have to push it through.
They’re not a free agent, but have to go through the OMB.
Eventually, they’re starting to see that that report is not going to
minimize the twin deliveries. We’ve done very well minimizing
triplets. [Physician #10]
Physicians may therefore also be somewhat ambivalent
about maximizing individual patient versus broader public
health benefits.
Despite possible needs for improvement in implementa-
tion and enforcement of policies, many providers feel that
SART is simply limited in its regulatory power, and that the
threat of losing one’s membership insufficiently motivates
physicians to follow guidelines:
The problem is that the only thing SART has to threaten doctors
with is non-membership, which some doctors would probably
welcome because then they wouldn’t have to pay or register
their results. By law, you’d still have to register with the CDC.
But that’s our dilemma: until we can create brand-name recog-
nition that a ‘SART-approved clinic’ is in fact superior, and
that clinics don’t become a member simply just by paying dues,
no one really cares – there’s not a whole lot of bite in being
removed from membership. [Physician #1]
These clinicians generally favour increasing professional
self-regulatory mechanisms first, before initiating govern-
ment regulations:
SART wants to set up guidelines for very stringent monitoring
of clinic performance, and ask clinics with poor performance
to change, taking steps from there. It should start with self-
regulation. There have been improvements over time. If there
isn’t continued improvement, it’s time for more regulation – as
in Scandinavian and other European countries. [Physician #1]
The threat of government regulation, if models of pro-
fessional self-regulation fail, could potentially enhance ad-
herence, though it has not yet proven sufficient.
Government regulations could potentially mandate
transfer of only one embryo at a time, but given patients’
financial constraints, may face opposition from patients,
unless costs are more fully covered. To reduce the incidences
of twins and other multiple births, other governmentpolicies, concerning insurance coverage, may also then
be needed:
If the government would mandate that insurance companies pay
for IVF, I would be the first to say: only do elective SET. I see the
result of twins and triplets, and the maternal complications for
ovarian stimulation – people hospitalized during an IVF cycle. But
patients and doctors are willing to do it, and try to transfer
more, and not be so cautious, because the patient is paying for it.
Different states have IVF mandates, and I would totally support
SET, or support PGD only for medical reasons. [Other provider #1]
Conclusions
These data, the first to explore several critical aspects of how
providers view and make decisions about how many embryos
to transfer, highlight how professional recommendations and
guidelines in this area can contain flexibility and ambiguities,
and lack enforcement, raising challenges, tensions and
dilemmas that providers and patients therefore confront.
While Højgaard et al. (2007) found that Danish patients faced
challenges (having toweigh their preferences for twins against
risks to the unborn children), the current data shed important
added light on why these challenges persist, and examine for
the first time how providers and patients respond to these
challenges. Specifically, while Højgaard et al. (2007) found
that most patients in a Danish clinic preferred DET, the
present data suggest that for various reasons, both patients
and providers often minimize the risks of twins. Though the
previous prior literature has focused largely on limitations in
insurance coverage as contributing to high rates of twins, the
present data suggest how other, non-economic factors –
social, psychological, cognitive, medical, logistical and pro-
fessional – can play critical roles as well. Though, as found in
Denmark, patients may still prefer twins, even in countries
that provide insurance, the present data probe how providers
and patients then confront and respond to ensuing tensions,
given professional recommendations favouring SET.
The present data also suggest possible strategies that have
not been previously reported for addressing these problems,
and several directions for future research. Specifically, eight
findings that have not been presented in the literature have
key implications for future research, practice, education and
guidelines. Firstly, while the past literature has focused on
either patient or provider views and decisions, the present
data highlight how these decisions can in fact be highly dyadic
and dynamic, involving both providers’ and patients’ attitudes
and perceptions concerning the risks.
Secondly, while Jungheim et al. (2010) found that 99% of
clinics routinely discuss with patients the number of embryos
to transfer, and 37% discuss SET with all patients, the
present data suggest how clinicians may in fact vary widely
in the quality of these discussions. These data extend and
build substantially on prior findings that the median length
of time of consulting about these issues with providers was
5 min (Kalra et al., 2003), and that a 10-minute consultation
with a nurse did not increase acceptability of SET to patients
(Murray et al., 2004). The present data add considerably
to the past literature, in suggesting that providers differ
considerably in what they actually say, how thoroughly they
discuss these issues; whether they communicate the risks
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(e.g., on the day of the transfer versus before). These data
suggest that providers may not fully explain or convey these
risks, and may even minimize them; and that patients may
also then minimize these dangers, or feel that these odds
do not apply to them.
Thirdly, while recommendations in certain countries
(e.g., the USA) suggest that transferring additional embryos
for women who seek them is justified if patients are
informed about the risks involved, the present data suggest
that patients may commonly misunderstand, minimize or
deny these risks. Patients may feel they don’t need to worry
about these dangers since the odds of each risk occurring
is b50% (i.e. 53.3% of twins are not born premature and
61.2% have normal birth weight) (Sazonova et al., 2013).
These data suggest that patients may seek rationalizations
for why these risks will not apply to them: for example
because they exercise and are healthy. Patients in other
areas of medicine commonly minimize or deny possible risks
to themselves (Rabinowitz and Peirson, 2006), and do so
here, too. Yet past research on patients’ perceptions of SET
have viewed these attitudes as fixed entities, and has not
explored the degree to which patients may misunderstand
the risks involved in any treatment. Physicians must obtain
informed consent, and patients thus need to understand the
risks and benefits involved, but the present data suggest that
that may not always occur. While Jungheim found that most
clinics deviated from guidelines, due to patient requests, the
current data suggest that patient requests themselves may
vary widely in how informed and firm they are. Therefore, the
present data suggest clinicians should not always simply follow
patient requests, but instead should ascertain how fully
informed and strong these requests are. Guidelines should,
arguably, also specify that providers should carefully discuss
specific relevant details with patients (e.g., risks, estimated
success rates, etc.), and the cumulative odds for at least one
of these risks occurring. Studies in other areas of medicine
show that patients may benefit most from being told not
either absolute or relative rates alone, but rather both, along
with proportions (e.g., ‘one out of ten,’ rather than ‘10%’ of
patients) (Lloyd, 2001; Peters et al., 2011).
Fourthly, these data suggest that physicians may fail to
follow SET due to not only their views of ‘patient autonomy’,
but due to their belief that the data on the risks faced
by twins are ‘not compelling’, thereby undermining efforts
to increase SET. These data also suggest, for the first
time, several reasons for these perceptions of the data as
insufficient. For any one patient, the odds of success with
twins are relatively good (i.e. 50% of twins will be healthy);
and individual clinicians may not consider the high costs that
hospitals and the health care system as a whole encounter,
partly because these providers do not observe or bear these
costs. Rather, paediatricians, not reproductive endocrinol-
ogy and infertility (REI) specialists, are responsible for,
and have experienced difficulties in, treating harmful out-
comes that twins face, for example in the NICU. Generally,
in assessing risks and benefits, individuals tend to have
cognitive ‘biases due to the retrievability of instances’,
outweighing their own personal experience of bad events
(Tversky and Kahneman, 1974). The risks may thus be easy
for REI specialists and prospective patients to discount.
The costs generated by these risks also accrue not to theseREI specialists, but to society and the eventual parents.
Individual patients may downplay the odds for themselves,
and providers may go along with these patients’ views and
desires, proceeding to fulfil patients’ requests and transfer
additional embryos, rather than discouraging patients.
Fifthly, these data suggest that providers may at times
transfer additional embryos due to their own competing
motives and pressures – desires, in many countries, to in-
crease their reported rates of success. Physicians may
therefore not always adequately communicate these dan-
gers to patients, and may be biased in arguing that patient
autonomy should readily trump all other considerations.
Sixthly, these data suggest that physicians may be over
prioritizing patient autonomy and ignoring or undervaluing
other ethical considerations – the rights of the unborn child,
beneficence toward these future offspring, non-maleficence
and social justice. In focusing on patient autonomy, physicians
may be downplaying their ethical responsibilities concerning
the future child, public health burdens to society as a whole
and the need to avoid harm to themother and future children.
Arguably, at a certain point, wider social and public health
costs and risks to themother and future offspringmay at times
outweigh the autonomy of an individual patient. Dilemmas
surface of precisely how much obligation providers have to
follow these other principles; yet clinicians should at least
seriously consider these other ethical concerns, especially
given both potential patient misunderstandings of risks, and
possibilities of physicians having conflicting motives.
Seventhly, while research has indicated that providers
may differ in how many embryos they transfer, the present
data suggest that clinicians also vary in how they make
these decisions: whether they do so informally or formally
(through an ethics or QA committee that may include not
only assisted reproductive technology providers). These data
suggest, too, that providers vary in these decisions due to
several factors, such as the type of institution in which they
work, and their own personal or professional experiences
and perceptions of the persuasiveness of the risk data.
Finally, while the prior literature has examined provider
and patient views dichotomously as either for or against SET
(versus DET), the present data also suggest how providers and
patients have difficulties because they in fact wrestle with
multiple sets of questions, comparisons and pros and cons,
including competing statistics regarding a patient’s prior
pregnancy success – weighing the relative risks and benefits
of SET against not just DET, but against having no baby.
Providers and patients may see SET as having advantages over
DET, but perceive DET as having advantages over no child –
thus focusing only on the outcome (to have a baby) rather than
on the risks as well. While SET can produce either one or no
baby, DET can yield two, one or zero offspring. Since the
patient’s overwhelming goal is to avoid zero, DET may seem,
on balance, a better bet statistically. Yet patients may
misunderstand and/or be unsure how to weigh these multiple
comparisons. Thus, provider and patient education should
focus on not just SET versus DET, but on these more complex
considerations as well, for example DET versus IVF failure.
These findings have several important implications for
further practice, policy, education and research. Though a
few commentators have suggested increasing insurance
coverage, doing so poses challenges: for example, the cost
of providing sufficient infertility care to everyone who wants
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several other approaches (e.g., improving provider-patient
communication about these complexities) can help. Atten-
tion and consensus are also needed on several key questions,
such as when a clinic’s rate of twins is too high, such that the
clinic should change its practices.
The success that a few countries, such as Belgium, have
had in lowering rates of twin births appears to result largely
from the fact that these countries’ national health services
cover a substantial part of the cost of IVF, and can there-
fore more effectively mandate restrictions on its use.
Governments can thus forcefully limit numbers of embryos
transferred as part of payments. In contrast, in many other
countries, where IVF is reimbursed much less or not at all,
recommendations to limit the numbers of embryos trans-
ferred face additional hurdles, and may have considerably
less success. Hence, countries can vary widely in use of
SET due to the presence of a single insurance payer. Given
competing economic and political priorities that can impede
the adoption of such policies, pursuing other potential ways
to increase SET use is thus critical.
Professional organizations and/or governments in many
countries should consequently develop additional guidelines,
and further encourage providers to decrease the number of
embryos transferred. For instance, current guidelines in the
USA, stating that for patients under 35 years of age ‘providers
should only transfer a single embryo, and not more than 2
embryos’, gives mixed messages, sanctioning transfer of two
embryos, and fuelling the continued epidemic of twins and
could be changed to state that physicians should ‘discourage’
DET in healthy young women, for example.
Improvements in clinics’ reporting requirements could
potentially help. In only 11 of 27 EU countries was public
access to data from individual clinics available in 2011
(Kupka et al., 2016). Reporting by clinics was voluntary in
14 EU countries, including Ireland, Spain and the Nether-
lands in 2006 – the most recent year for which such
information is available on the website for the European
Society for Human Reproduction and Embryology (ESHRE)
(ESHRE, 2009). Increasing public access to individual clinic
data, and requiring reporting by clinics may therefore be
helpful as well. Professional organizations and/or govern-
ment agencies could all explicitly collect and publish the
success rates of SET versus DET. In many countries, current
reporting requirements disincentivize providers from trans-
ferring fewer embryos. For instance, between 2005 and
2010, the proportion of cycles that US IVF programmess
failed to report increased from 3.3% to 7.4%. Of these
clinics, 3.8% performed 50% of these excluded cycles, which
totalled 37% of these Centers’ entire cycles (Kushnir et al.,
2013), and these clinics consequently reported much better
pregnancy rates, and increased their share of US assisted
reproductive technology cycles by 19.9%. The researchers
analysing these data therefore found lessened transparency of
reporting, and recommended prospective reporting of each
initiated cycle by all clinics. Williams et al. (2015), reviewing
subsequent debates about additional data reporting to SART,
concluded that several changes are needed: reporting not only
all cycle initiations prospectively, but cycle outcomes on an
embryo transfer basis, perinatal assisted reproductive tech-
nology outcomes, assisted reproductive technology outcomes
adjusted for risks (e.g., age, body mass index, duration offertility), and clinics’ concordance with the ASRM’s recom-
mended limits for number of embryos transferred, and in-
creased comprehensibility of these data by patients (Williams
et al., 2015). Proponents of SET have emphasized the need
for increased insurance coverage for assisted reproductive
technology and improved education of patients (Kissin et al.,
2015); yet the present data suggest that changing reporting
requirements may help as well.
Such alterations in reporting requirements will likely
encounter resistance (Gleicher, 2004), but the present data
add further support to efforts to expand reporting in these
ways, highlighting how current reporting is limited, fuels
misunderstanding and may be self-serving. Better, fuller
reporting would provide more transparency, and perhaps
implicit strategies of ‘naming and shaming’ non-adherent
clinics. Moreover, SART, for instance, currently cautions
viewers of its reports that the data should not be used
for comparing clinics. Yet for patients, who are eager to find a
clinic, the publication of each participating clinics’ rates on
one site inevitably invites such comparisons. Hence, helping
patients to make such comparisons, for example by publishing
additional data (such as each clinic’s sociodemographic and
prior obstetrical or medical data), may be helpful.
These findings also underscore needs to enhance profes-
sional, patient and public education about the risks of twins
and other multiple births. Patients may think, for instance,
that since, on average, only 50% of embryos will succeed,
transferring two should lead to a successful pregnancy. Yet
many patients will still then end up with twins, while other
prospective parents remain childless. Clinicians, especially
if they are transferring extra embryos, should proceed with
care, and rigorously ensure that patients fully grasp these
risks. The data also suggest a need to develop decision-
making tools for patients, to help them grasp the relative
risks, benefits and costs to them. Given ongoing media
reports of celebrities and others having twins, education of
journalists about the risks involved can also be beneficial.
These data suggest several avenues for future research.
Quantitative studies of patient attitudes have assessed
preferences for DET versus SET (Leese and Denton, 2010;
Murray et al., 2004), but only one study has explored the
strength of those preferences – specifically, examining how
desirability of twins on a 1 to 6 scale correlated with recent
high, low or medium risk information (Newton et al., 2007) –
and no studies have examined patients’ understanding,
misunderstanding and acceptance or minimization of these
risks (i.e. perceptions of how applicable these risks are), or
how differences within a couple get negotiated. The present
data underscore the need to examine exactly what risks
providers convey to patients; how much time clinicians
spend doing so, and how effectively; how often patients
seeking DET minimize the risks; how often providers using
DET feel the risk data about twins are insufficiently
compelling; what they feel the risks in fact are; what odds
they feel would be compelling enough to switch to SET; and
how they weigh these risks against other considerations.
Some providers have begun to use SET with single
blastocyst transfer after pre-implantation genetic screen-
ing. However, data are lacking on how frequently providers
in various countries are adopting this practice. Moreover, for
the reasons described here, many patients will presumably
still prefer to have twins, rather than singletons.
13How many embryos to transferThese data have several potential limitations. The sample
size is sufficient for qualitative research designed to elucidate
the issues and themes that emerge; however, future studies
using larger samples are needed to analyse statistically how
various groups may differ (e.g., physicians versus patients).
This study was also designed to shed light on the range of
providers’ and patients’ experiences, views and interactions
concerning these issues, rather than to quantify the percent-
ages of different types of respondents who adopted each of
these attitudes and behaviours. However, future studies can
measure the rates at which these phenomena occur in larger
samples in multiple countries. As the first data to probe these
issues, inter-rater reliability was not calculated statistically;
however, future studies, using larger samples can do so.
Moreover, these data appear to have a certain face validity,
illuminating challenges that many patients and providers
confront. These interviewees worked in the USA; yet
extensive literature searches indicate a lack of data address-
ing these questions in other countries, and arguably, similar
challenges and tensions exist in many other countries as well.
These interviews were also conducted at one point in time.
Future studies can thus examine providers’ and patients’
attitudes and practices in other countries, and whether these
shift over time, and if so, how. Yet, enrolment of physicians
and other providers is also difficult. Healthcare providers are
increasingly difficult to recruit for surveys, as indicated
by response rates declining over time (Cho et al., 2013; Cull
et al., 2005).
In summary, these data, the first to explore several
critical aspects of decisions concerning how many embryos
physicians should transfer following IVF, have vital implica-
tions for future practice, research, policy and education.Acknowledgements
The author would like to thank Patricia Contino, MFA, Sarah J.
Kiskadden-Bechtel, BA, Rebecca Pol, and Andrew Rock, BA for their
assistance in preparation of this manuscript. Research for this paper
is supported by grant number UL1 RR024156 from the National
Centre for Research Resources (NCRR), The Greenwall Foundation,
and the John Simon Guggenheim Memorial Foundation.
Appendix A. Sample questions for providers
What challenges do you face in your work as an assisted
reproductive technology provider?
How do you address the challenges?
Have you faced challenges concerning the number of
embryos to transfer to a patient? If so, when? What was
difficult about the situation? What did you do? How did you
make these decisions?
How do you view these issues?
How have your patients viewed these issues?
What additional thoughts do you have about these issues?References
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